📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.SPARCPharmaceuticals
Open
129.4
High
130.31
Low
123.25
Close
124.94
Volume
479073
Exchange
nse
Time
23-Jan-2026

Outlook

Score:  

2

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Sun Pharma Advanced Research Company is  
Long Body
Estimated Stoploss of Sun Pharma Advanced Research Company is ₹  
130.31
Sun Pharma Advanced Research Company has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Sun Pharma Advanced Research Company maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Sun Pharma Advanced Research Company is in  
Sideways trendℹ
. 
Price of Sun Pharma Advanced Research Company is  
Downℹ
 by  

7.56

%. 
Target
Buy @ 

123.64

Sell @ 

147.98

Current @ 

124.94

Volume

The trade volumes of Sun Pharma Advanced Research Company have become  
Deficientℹ
The volume trend for Sun Pharma Advanced Research Company is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Sun Pharma Advanced Research Company is  

Down

 by  

90.08

% 

Valuation

The current market price of Sun Pharma Advanced Research Company is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 335cr and total assets worth ₹ 335cr, the balance sheet of Sun Pharma Advanced Research Company is:  
Balancedℹ
. 
Cashflow
Sun Pharma Advanced Research Company has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 3cr

. It is  
Downℹ
 by  

175

%. 

(*Mar 2025)

50.28% i.e. ₹ 360cr spent in operatingℹ
21.93% i.e. ₹ 157cr earned in investingℹ
27.79% i.e. ₹ 199cr earned in financingℹ
0% in otherℹ
Sun Pharma Advanced Research Company has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 4cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2024)

49.77% i.e. ₹ 429cr spent in operatingℹ
45.36% i.e. ₹ 391cr earned in investingℹ
4.87% i.e. ₹ 42cr earned in financingℹ
0% in otherℹ
Income
The income of Sun Pharma Advanced Research Company is  

₹ 7cr

 and  

Loss

 is :  

₹ 75cr

(*Sep 2025)

Sun Pharma Advanced Research Company Losses increased by:  

47.06

% and Income is Down by:  

61.11

% 

(*Sep 2025)

The income of Sun Pharma Advanced Research Company is  

₹ 18cr

 and  

Loss

 is :  

₹ 51cr

(*Jun 2025)

Sun Pharma Advanced Research Company Losses decreased by:  

13.56

% and Income is Down by:  

33.33

% 

(*Jun 2025)

The income of Sun Pharma Advanced Research Company is  

₹ 27cr

 and  

Loss

 is :  

₹ 59cr

(*Mar 2025)

Sun Pharma Advanced Research Company Losses decreased by:  

25.32

% and Income is Up by:  

80

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.